Valuation of Square Pharma

Company Background strong Pharmaceuticals special(a) has been a household design in Bangladesh since 1958 when it started its operations as a partnership, getting coordinated in 1964 and finally getting listed at the stock convince in 1995. The company has been in the leading front of innovation, and continues to bring in new and better medicines in the market place every year. instantly the 97% of the demands for medicine in the domestic market is catered to by the local pharmaceuticals company and Square Pharmaceuticals limited has captured a solid portion of this market. The company has been growing consistently for over the years, and their harvesting has exceeded the growth of the application growth at times. |Years |1999 | |Square Pharmaceuticals Limited |20.06 | |Incepta Pharmaceuticals Limited |7.53 | |Beximco Pharmaceuticals Limited |7.09 | |The Acme Laboratories Limited |5.25 | |Eskayef Pharmaceuticals Limited |4.64 | |ACI Limited |4.52 | |Opsonin Chemical Industries Limited |4.

30 | |Renata Limited |4.22 | |Aristopharma Limited |4.18 | | drug International Limited |3.39 | [pic] Source: IMS fourth quarter, 2008 The market is oligopolistic in nature and is thus dominated by high levels of main course and foul barriers, considering the first mover advantage already achieved by the dominating firms in the form of economies of scale. Besides this, origination into this market also requires heavy capital expenditure which is also translated into exit barriers, in the form of high sunk cost. Additionally, government rules pertaining to the industry to maintain standards also acts as a form of entry barriers. Even though the products of the firms are comparable in nature because of... If you want to get a full essay, order it on our website: Ordercustompaper.com

Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!